Lipoprotein lipase locus and progression of atherosclerosis in coronary-artery bypass grafts

Genetics in Medicine

Volumn 6, Issue 6, 2004, Pages 481-486

  Taylor, Kent D ^a   Scheuner, Maren T ^a   Yang, Huiying ^a   Wang, Yaping ^a   Haritunians, Talin ^a   Fischel Ghodsian, Nathan ^a   Shah, Prediman K ^a   Forrester, James S ^a   Knatterud, Genell ^b   Rotter, Jerome I ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Coronary arteriosclerosis; Coronary artery bypass grafts; Lipoprotein lipase; Lovastatin

Indexed keywords

LIPOPROTEIN LIPASE;

3' UNTRANSLATED REGION; ADULT; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

ARTERIOSCLEROSIS; CHOLESTYRAMINE; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DEOXYRIBONUCLEASE HINDIII; FEMALE; GENOTYPE; HUMANS; LIPOPROTEIN LIPASE; LOVASTATIN; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; SAPHENOUS VEIN;

EID: 9644275539     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000144012.18935.48     Document Type: Article

References (42)

1. Post-CABG Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997;336:153-162.
2. Lusis AJ. Atherosclerosis. Nature 2000;407:233-24.
3. Benlian P, De Gennes JL, Foubert L, Zhang H, Gagne SE, Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 1996;335:848-854.
4. Mailly F, Tugrul Y, Reymer PW, Bruin T, Seed M, Groenemeyer BF et al. A common variant in the gene for lipoprotein lipase (Asp9->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arteriosder Thromb Vasc Biol 1995;15:468-478.
5. VVittrup HH, Tybjaerg-Hansen A, Steffensen R, Deeb SS, Brunzell JD, Jensen G et al. Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study. Arterioscler Thromb Vasc Biol 1999;19:1535-1540.
6. Kastelein JJ, Groenemeyer BE, Hallman DM, Henderson H, Reymer PW, Gagne SE et al. The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group. Clin Genet 1998;53:27-33.
7. Ruel IL, Gaudet D, Perron P, Bergeron J, Julien P, Lamarche B. Characterization of LDL particle size among carriers of a defective or a null mutation in the lipoprotein lipase gene: the Quebec LIPD Study. Arterioscler Thromb Vasc Biol 2002;22:1181-1186.
8. Jukema JW, van Boven AJ, Groenemeijer B, Zwinderman AH, Reiber JH, Bruschke AV et al. The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. Circulation 1996;94:1913-1918.
9. Reymer PW, Gagne E, Groenemeyer BE, Zhang H, Forsyth I, Jansen H et al. A lipoprotein lipase mutation (Asn291Ser) isassociated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet 1995;10:28-34.
10. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 1999;99:2901-2907.
11. Pimstone SN, Clee SM, Gagne SE, Miao L, Zhang H, Stein EA et al. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res 1996;37:1675-1684.
12. Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ et al. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. Circulation 1997;96:733-740.
13. Mero N, Suurinkeroinen L, Syvanne M, Knudsen P, Yki-Jarvinen H, Taskinen MR. Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant. J Lipid Res 1999;40:1663-1670.
14. Wittrup HH, Tybjaerg-Hansen A, Abildgaard S, Steffensen R, Schnohr P, Nordestgaard BG. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J Clin Invest 1997;99:1606-1613.
15. Klannemark M, Suurinkeroinen L, Orho-Melander M, Groop L, Taskinen MR. Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus. Diabet Med 2000;17:599-605.
16. Wang XL, McCredie RM, Wilcken DE. Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation 1996;93:1339-1345.
17. Mattu RK, Needham EW, Morgan R, Rees A, Hackshaw AK, Stocks J et al. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 1994;14:1090-1097.
18. Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992;97:171-185.
19. Chen L, Patsch W, Boerwinkle E. HindIII DNA polymorphism in the lipoprotein lipase gene and plasma lipid phenotypes and carotid artery atherosclerosis. Hum Genet 1996;98:551-556.
20. Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J et al. Association of lipoprotein lipase gene polymorphisms with coronary artery disease. J Am Coll Cardiol 1999;33:1013-1020.
21. Ahn YI, Ferrell RE, Hamman RF, Kamboh MI. Association of lipoprotein lipase gene variation with the physiological components of the insulin-resistance syndrome in the population of the San Luis Valley, Colorado. Diabetes Care 1993;16:1502-1506.
22. Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, Stengard J et al. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet 1998;19:233-240.
23. Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan A, Stengard J et al. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet 1998;63:595-612.
24. Templeton AR, Clark AG, Weiss KM, Nickerson DA, Boerwinkle E, Sing CF. Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet 2000;66:69-83.
25. Templeton AR, Weiss KM, Nickerson DA, Boerwinkle E, Sing CF. Cladistic structure within the human Lipoprotein lipase gene and its implications for phenotypic association studies. Genetics 2000;156:1259-1275.
26. Anderson MA, Gusella JF. Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro 1984;20:856-858.
27. Miller G, Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A 1973;70:190-194.
28. Freshney R. Culture of animal cells: A manual of basic techniques. New York: Liss, 1987.
29. Pressman S, Rotter JI. Epstein-Barr virus transformation of cryopreserved lymphocytes: prolonged experience with technique. Am J Hum Genet 1991;49:467.
30. Sambrook J, Fritsch E, Maniatis T. Molecular cloning. New York: Cold Spring Harbor Laboratory, 1989.
31. Li SR, Oka K, Gallon D, Stocks J. Pvu-II RFLP at the human lipoprotein lipase (LPL) gene locus. Nucleic Acids Res 1988;16:2358.
32. Zuliani G, Hobbs HH. Tetranucleotide repeat polymorphism in the LPL gene. Nucleic Acids Res 1990;18:4958.
33. Heizmann C, Kirchgessner T, Kwiterovich PO, Ladias JA, Derby C, Antonarakis SE et al. DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet 1991;86:578-584.
34. SAS Institute [computer program]. Release 6.12. Cary, NC: SAS Institute, 1997.
35. Wu DA, Bu X, Warden CH, Shen DD, Jeng CY, Sheu WH et al. Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. J Clin Invest 1996;97:2111-2118,35.
36. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
37. Bloomgarden ZT. Genes and the cell biology of insulin secretion and insulin resistance. Diabetes Care 1999;22:849-853.
38. Goodarzi MO, Guo X, Taylor KD, Quinones MJ, Saad MF, Yang H et al. Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. Diabetes 2004;53:214-220.
39. Xiang AH, Azen SP, Buchanan TA, Raffel LJ, Tan S, Cheng LS et al. Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent. Arterioscler Thromb Vasc Biol 2002;22:843-848.
40. Ferreira LD, Pulawa LK, Jensen DR, Eckel RH. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes 2001; 50:1064-1068.
41. Renier G, Lambert A. Lipoprotein lipase synergizes with interferon gamma to induce macrophage nitric oxide synthetase mRNA expression and nitric oxide production. Arterioscler Thromb Vasc Biol 1995;15:392-399.
42. Sartippour MR, Lambert A, Laframboise M, St-Jacques P, Renier G. Stimulatory effect of glucose on macrophage lipoprotein lipase expression and production. Diabetes 1998;47:431-438.